There is wide variation in the performance of commercial kits for detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a new study.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200924141549.htm
No comments:
Post a Comment